Advanced search
Publication Cover
Expert Review of Anti-infective Therapy Volume 4, 2006 - Issue 5
Submit an article Journal homepage
1,157
Views
18
CrossRef citations to date
0
Altmetric
Editorial

Is there value in susceptibility testing of Pseudomonas aeruginosa causing chronic infection in patients with cystic fibrosis?

Peter H Gilligan University of North Carolina, Clinical Microbiology-Immunology Laboratories, UNC Hospitals, CB 7600, Chapel Hill, NC 27514, USA. [email protected]
Pages 711-715 | Published online: 10 Jan 2014

Citations (18)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Peter Greally, Paul Whitaker & Daniel Peckham. (2012) Challenges with current inhaled treatments for chronic Pseudomonas aeruginosa infection in patients with cystic fibrosis. Current Medical Research and Opinion 28:6, pages 1059-1067.
Read now

Articles from other publishers (17)

Sherie Smith, Valerie Waters, Nikki Jahnke & Felix Ratjen. (2020) Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis. Cochrane Database of Systematic Reviews 2021:4.
Crossref
Vidya P. Narayanaswamy, Laura L. Keagy, Kathryn Duris, William Wiesmann, Allister J. Loughran, Stacy M. Townsend & Shenda Baker. (2018) Novel Glycopolymer Eradicates Antibiotic- and CCCP-Induced Persister Cells in Pseudomonas aeruginosa. Frontiers in Microbiology 9.
Crossref
Shawn T Clark, David S Guttman & David M Hwang. (2018) Diversification of Pseudomonas aeruginosa within the cystic fibrosis lung and its effects on antibiotic resistance. FEMS Microbiology Letters 365:6.
Crossref
Valerie Waters & Felix Ratjen. (2017) Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis. Cochrane Database of Systematic Reviews.
Crossref
Valerie Waters & Felix Ratjen. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Axel Dalhoff. (2014) Pharmacokinetics and Pharmacodynamics of Aerosolized Antibacterial Agents in Chronically Infected Cystic Fibrosis Patients. Clinical Microbiology Reviews 27:4, pages 753-782.
Crossref
Peter H. Gilligan. (2014) Infections in Patients with Cystic Fibrosis. Clinics in Laboratory Medicine 34:2, pages 197-217.
Crossref
Valerie Waters & Felix Ratjen. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Deanna L. Kiska & Scott W. Riddell. (2012) Practical Laboratory Aspects of Cystic Fibrosis Microbiology: an Update, Part II. Clinical Microbiology Newsletter 34:5, pages 35-41.
Crossref
Michael D. Parkins, Jacqueline C. Rendall & J. Stuart Elborn. (2012) Incidence and Risk Factors for Pulmonary Exacerbation Treatment Failures in Patients With Cystic Fibrosis Chronically Infected With Pseudomonas aeruginosa. Chest 141:2, pages 485-493.
Crossref
Valerie Waters & Felix Ratjen. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Maarten Fauvart, Valerie N. De Groote & Jan Michiels. (2011) Role of persister cells in chronic infections: clinical relevance and perspectives on anti-persister therapies. Journal of Medical Microbiology 60:6, pages 699-709.
Crossref
Samuel M. Moskowitz, Julia C. Emerson, Sharon McNamara, Richard D. Shell, David M. Orenstein, Daniel Rosenbluth, Marcia F. Katz, Richard Ahrens, Douglas Hornick, Patricia M. Joseph, Ronald L. Gibson, Moira L. Aitken, Wade W. Benton & Jane L. Burns. (2010) Randomized trial of biofilm testing to select antibiotics for cystic fibrosis airway infection. Pediatric Pulmonology 46:2, pages 184-192.
Crossref
Lawrence R. Mulcahy, Jane L. Burns, Stephen Lory & Kim Lewis. (2010) Emergence of Pseudomonas aeruginosa Strains Producing High Levels of Persister Cells in Patients with Cystic Fibrosis . Journal of Bacteriology 192:23, pages 6191-6199.
Crossref
D. Macdonald, L. Cuthbertson, C. Doherty, S. Campana, N. Ravenni, G. Taccetti & J. R. W. Govan. (2010) Early Pseudomonas aeruginosa infection in individuals with cystic fibrosis: is susceptibility testing justified?. Journal of Antimicrobial Chemotherapy 65:11, pages 2373-2375.
Crossref
Julia Emerson, Sharon McNamara, Anne Marie Buccat, Kelly Worrell & Jane L. Burns. (2010) Changes in cystic fibrosis sputum microbiology in the United States between 1995 and 2008. Pediatric Pulmonology 45:4, pages 363-370.
Crossref
T. Spasenovski, M. P. Carroll, A. K. Lilley, M. S. Payne & K. D. Bruce. (2010) Modelling the bacterial communities associated with cystic fibrosis lung infections. European Journal of Clinical Microbiology & Infectious Diseases 29:3, pages 319-328.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.